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THE intercellular adhesion molecule-1 (ICAM-1) was
found by immunostaining chondrocytes in cartilage from
three patients with rheumatoid arthritis. Expression of
ICAM-1 was restricted to chondrocytes in areas of eroded
cartilage adjacent to the invading synovial tissue.
Toluidine blue staining of these areas demonstrated severe
depletion of the cartilage extracellular matrix. In areas of
undamaged cartilage there was no ICAM-1 expression.
Since ICAM-1 is not constitutively expressed on normal
human articular cartilage, but could be induced in vitro
by exogenous IL-I, TNF and IFNy or by co-culturing
cartilage with inflammatory rheumatoid synovium, we
conclude that the induction of ICAM-1 on rheumatoid
chondrocytes results from the synergistic action of a
variety of cytokines produced by the inflammatory cells of
the invading pannus.
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Introduction
Rheumatoid arthritis (RA) is an autoimmune
inflammatory disease characterized by infiltration of
the cartilage matrix by inflamed synovial tissue
which ultimately destroys the joint. Although the
mechanism initiating the process of inflammatory
invasion is unknown, it is presumed to involve an
active and self-perpetuating immune response as
indicated by the presence of large numbers of
activated T-cells, macrophages, fibroblasts and
plasma cells. 1’2 This cellular environment is a rich
source of cytokines e.g., IL-1, TNFoq PDGF, IL-6,
GM-CSF, IFN
2 which may function in a variety of
processes, including induction of activation mark-
ers on both synovial cells2 and chondrocytes,3’4 the
indigenous cell of the cartilage.
One such activation marker is HLA Class II,
expression of which is a prerequisite for antigen
presentation and the subsequent initiation of an
immune response. Class II has been demonstrated
on RA chondrocytes possibly due to the synergistic
action of synovial IFN, TNFo and GM-CSF,
2 and
evidence of the ability of chondrocytes to present
autoantigens is also available.
Maintenance of expression of Class II and
efficient antigen presentation is now thought to
require the aid of cell adhesion molecules such as
ICAM-1. 2’6 Since we have already shown ICAM-1
to be inducible by IL-1 on normal human articular
cartilage in vitro, it would obviously be of interest
to know whether this potentially important
molecule is expressed under the pathophysiological
conditions of the inflamed joint.
(C) 1992 Rapid Communications of Oxford Ltd
In the present study we have investigated the in
vivo expression of ICAM-1 on human rheumatoid
cartilage chondrocytes and have demonstrated
the requirement for cytokines in its induction.
Our findings provide additional evidence for
the involvement of cytokines and chondrocyte-
inflammatory cell interactions in the pathogenesis
of rheumatoid arthritis.
Materials and Methods
Rheumatoid cartilage was obtained following hip
and knee replacement surgery from three patients,
a 40 year-old c, 59 year-old 9 and a 48 year-old c,
all suffering from RA as defined by the American
Rheumatism Association. The patients had been
treated with non-steroidal anti-inflammatory drugs.
The extent of cartilage damage in the rheumatoid
joints was assessed as far as possible macroscopic-
ally and two to three adjacent cartilage explants
were removed from each different area as soon as
possible after surgery. The explants were frozen in
O.C.T. embedding medium (Miles Diagnostics) and
stored at -70C until used for immunohistology.
Normal articular cartilage was obtained postoperat-
ively from selected patients having no recorded
history of inflammatory joint disease. In the
experiments described here the patients were both
male, aged 61 and 80, and receiving no medication.
The cartilage explants were used within 6 h and
were either frozen immediately in O.C.T. and
stored at -70C to provide ex vivo control tissue,
or were cultured under standard conditions as
described previously in DMEM +5% foetal calf
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serum (i) in the presence of different concentrations
of exogenous human recombinant IL-I, TNF0 or
IFN for 4b-6 days or (ii) in contact with several
different samples of human inflammatory rheuma-
toid synovium using the method described
previously.
4
Immunohistology was performed on 6-9/m
frozen sections of the cartilage as already described
in detail elsewhere except that, in the present study,
the primary antibody was a mouse anti-human
ICAM-1, prepared and characterized at British
Biotechnology
7 and the secondary antibody was
biotinylated goat anti-mouse Ig/streptavidin-HRP
complex (Sigma Poole, Dorset, UK). After
development of the colour reaction using dia-
minobenzidine as substrate, the sections were
mounted and viewed with a Nikon diaphot
microscope fitted with epifluorescence.
Results
ICAM-1 expression on rheumatoid cartilage: By indirect
immunolocalization we demonstrated staining for
ICAM-1 on chondrocytes in diseased cartilage
removed from knee and hip joints from three
patients with rheumatoid arthritis. From each
patient two to three explants removed from areas
of badly damaged, medium or undamaged cartilage
were examined. In all three patients expression of
1CAM-1 was observed on chondrocytes in areas of
damaged cartilage adjacent to the invading
synovium (Fig. 1). Although cells were sparse, the
majority showed positive staining. These areas of
cartilage appeared eroded by both macroscopical
and microscopical examination, and toluidine blue
staining showed extensive depletion of the
extracellular matrix proteoglycans. In the samples
examined so far chondrocytes in the subarticular
and midzones of the cartilage did not express
ICAM-1.
Some positive staining was observed at restricted
sites in the synovial tissue, indicating ICAM-1
expression by a small proportion of the in-
flammatory cells.
Cartilage explants removed from areas distant
from the invading pannus appeared undamaged and
there was no evidence of ICAM-1 expression .by the
chondrocytes.
Experimental induction ofICAM-1 on normal cartilage
(i) By in vitro culture with cytokines: We have shown
previously that ICAM-1 is not expressed constitut-
ively on normal human cartilage chondrocytes, but
can be induced during in vitro culture with IL-10.
FIG. 1. Expression of ICAM-1 on chondrocytes (arrowed) in human rheumatoid arthritic cartilage.
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Table 1. Dose-response and time-course of induc-
tion of ICAM-1 by cytokines on chondrocytes in
normal human cartilage*
Time in culture
4 h 24 h 6 days
Dose of L-
(ng/ml)
0.1
1.0
2.0
Dose of TNFz
(ng/ml)
1.0
5.0
10.0
Dose of FN7
(ng/ml)
0.1
1.0
10.0
+ +
++ ++
+++ ++
+ +
+ +
++ +
+ +
+ +
++ +++
* No cells staining (-)’ majority (>80%) of cells
staining weakly(__+), moderately (+), strongly
(+ +), very intensely (+ + +).
In the present study we have shown that like IL-I
both TNF0 (dose range 1.0-10.0 ng ml-1) and IFN
(dose range 0.1-10.0 ng m1-1) had no effect at 4 h
but were able to induce ICAM-1 expression
comparable with IL-10 during culture for 24 h-6
days. The dose-response and time-course experi-
ments were done twice on both normal cartilage
samples and the combined results are presented in
Table 1.
(ii) By co-culture with rheumatoid synovium When normal
human articular cartilage was co-cultured in close
contact with minced inflammatory rheumatoid
synovium strong expression of ICAM-1 was
induced on the chondrocytes (Fig. 2). The most
intense staining was seen on cells in close proximity
to the synovial tissue. Moving away from the
synovium the intensity of staining gradually
reduced as the distance increased, until all cells were
negative for ICAM-1.
Marked expression of the adhesion molecule was
also demonstrated on clusters of cells within the
synovial tissue.
This experiment has been repeated on three
separate occasions using different samples and has
yielded the same results each time.
Discussion
Our observation that chondrocytes in diseased
human rheumatoid cartilage express the adhesion
FIG. 2. Co-culture of normal human cartilage with inflammatory rheumatoid synovium. Note the expression of ICAM-1 on chondrocytes (arrows)
and on synovial cells, syn, synovium" cart, articular cartilage.
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molecule, ICAM-1 has revealed both a new marker
of cytokine activation and possibly a novel role for
the chondrocyte in cell-cell interactions.
We have shown that chondrocytes in normal,
undamaged cartilage do not express 1CAM-17 but
require activation by pro-inflammatory cytokines
such as IL-I, TNF or IFN, a finding consistent
with reports of 1CAM-1 expression in other cell
types.
6,9
In rheumatoid cartilage, expression of the
adhesion molecule was found to be restricted to
areas of damaged and proteoglycan-depleted
cartilage at the junction with the overlying pannus.
This observation suggests a very localized action of
inflammatory mediators presumably originating
from the synovial infiltrate. Our co-culture
experiment confirmed that inflammatory synovium
is a very effective inducer of 1CAM-1 on
chondrocytes, due to its production of adequate
amounts of the necessary activating cytokines e.g.
IL-lo and /, TNFo and IFN..
4’1’11 Although we
have demonstrated the effectiveness of these
individual cytokines in vitro, the situation is more
complicated in the inflammatory microenvironment
in RA, where these mediators will be acting perhaps
synergistically and certainly in concert with a
variety of growth factors (TGF fl, PDGF, IGF1
and GM-CSF) as well as with inhibitors or
antagonists.
12 As far as we know, this is the first
reported observation of ICAM-1 expression by
chondrocytes under pathophysiological conditions.
Further experiments are now in progress to assess
(i) whether this is a general phenomenon of RA
cartilage and (ii) how expression of the adhesion
molecule is regulated in this complex microenviron-
ment. The co-culture would seem to provide a
suitable in vitro model for investigation of the
mechanisms of chondrocyte activation, expression
of adhesion molecules, and their roles in the
regulation of cartilage extracellular matrix turnover.
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